CCEL vs CLX · P/E 490, $39.6M cap vs P/E 15, rev $7.10B
CryoCell International Inc (CCEL) versus The Clorox Company (CLX) — a side-by-side from cached financials, not a winner call.
CryoCell International Inc (CCEL) is a medical care facilities company listed on US.
The Clorox Company (CLX) is a household & personal products company listed on US.
CCEL does not have a complete income-statement cache yet.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. Revenue was up 0.2% from 2024-06-30 to 2025-06-30. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
CCEL currently screens at market cap $39.6M and trailing P/E 490.0. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Not investment advice. Open the CCEL and CLX stock pages for the full models.
Not investment advice.